Are you Dr. Segal?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 6 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
435 E 70th St
APT 10K
New York, NY 10021Phone+1 917-509-7176
Summary
- Dr. Jeremy Segal, MD is a board certified pathologist in New York, New York. He is currently licensed to practice medicine in New York, Indiana, and Illinois. He is affiliated with University of Chicago Medical Center.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 2007 - 2010
Weill Cornell MedicineClass of 2007
Certifications & Licensure
IL State Medical License 2013 - 2026
IN State Medical License 2024 - 2025
NY State Medical License 2010 - 2013
PA State Medical License 2010 - 2011- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 25 citationsGermline BRCA-associated Endometrial Carcinoma is a Distinct Clinicopathologic Entity.Marthe M de Jonge, Lauren L. Ritterhouse, Cornelis D. de Kroon, Maaike P.G. Vreeswijk, Jeremy P. Segal
Clinical Cancer Research. 2019-12-15 - 7 citationsFollicular Thyroid Neoplasms: Comparison of Clinicopathologic and Molecular Features of Atypical Adenomas and Follicular Thyroid CarcinomasVincent Cracolici, Lauren L. Ritterhouse, Jeremy P. Segal, Rutika Puranik, Pankhuri Wanjari
The American Journal of Surgical Pathology. 2020-07-01 - 30 citationsEWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma.Khaleel I Al-Obaidy, Julia A. Bridge, Liang Cheng, Janos Sumegi, Victor E. Reuter
Modern Pathology. 2021-06-07
Press Mentions
Eyes on Faster, Cheaper, Simpler Next-Gen SequencingMay 19th, 2021
